Skip to main content


In a post hoc pooled analysis, what conclusion did Van de Kerkhof et al reach regarding the safety of tildrakizumab in patients aged 65 years and older?
At Winter Clinical Dermatology Conference, David M. Pariser, MD, presented on hyperhidrosis and offered a number of pearls to take to practice.
In an interview with The Dermatologist, Dr Boh highlighted some important insights into the off-label use of biologics.
Mark Nestor, MD, PhD, shares his top pearl for marketing your aesthetics practice in this 1-minute video.
Back to Top